HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feline Acquired Immunodeficiency Syndrome (FAIDS)

Acquired defect of cellular immunity that occurs in cats infected with feline immunodeficiency virus (FIV) and in some cats infected with feline leukemia virus (FeLV).
Also Known As:
FAIDS; Feline Acquired Immune Deficiency Syndrome; Feline Acquired Immuno-Deficiency Syndrome; Feline Acquired Immuno Deficiency Syndrome; AIDS, Feline; Feline AIDS
Networked: 30 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infections
2. Viremia
3. Feline Acquired Immunodeficiency Syndrome (FAIDS)
4. Superinfection
5. Acquired Immunodeficiency Syndrome (AIDS)

Experts

1. Richardson, Jennifer: 2 articles (02/2009 - 03/2008)
2. Bendinelli, Mauro: 2 articles (06/2008 - 10/2007)
3. Ciccozzi, Massimo: 2 articles (06/2008 - 10/2007)
4. Ciervo, Alessandra: 2 articles (06/2008 - 10/2007)
5. D'Ostilio, Daniela: 2 articles (06/2008 - 10/2007)
6. Mancini, Fabiola: 2 articles (06/2008 - 10/2007)
7. Pistello, Mauro: 2 articles (06/2008 - 10/2007)
8. Savarino, Andrea: 2 articles (06/2008 - 10/2007)
9. Taglia, Fabiana: 2 articles (06/2008 - 10/2007)
10. Auwerx, Joeri: 1 article (02/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Feline Acquired Immunodeficiency Syndrome:
1. VaccinesIBA
2. Anti-Retroviral Agents (Antiretroviral Agents)IBA
3. VanadiumIBA
4. Anti-Infective Agents (Microbicides)IBA
5. bis(cyclopentadienyl)- N,N- diethyldithiocarbamato triflate saltIBA
6. 6- dihydro- 3'- azidothymidine- 5'- (p- bromophenyl) methoxyalaninyl phosphate 5-bromo-6-methoxy-5IBA
7. AvemarIBA
8. Interferon-alpha (Interferon Alfa)IBA
01/01/1990 - "AZT inhibited replication of an immunodeficiency-inducing strain of feline leukemia virus (FeLV-FAIDS) in vitro at concentrations as low as 0.005 microgram/mL. This antiviral activity was augmented an additional 25-30% when AZT was combined with human recombinant alpha-interferon (2b) (IFN alpha). "
09/01/1990 - "The therapeutic efficacies of human recombinant alpha interferon (IFN-alpha), IFN-alpha plus zidovudine (AZT), and AZT alone were evaluated in presymptomatic cats with established feline leukemia virus (FeLV)-acquired immunodeficiency syndrome (FAIDS) infection and high levels of persistent antigenemia. "
01/01/1990 - "Zidovudine (3'-azido-3'-deoxythymidine; AZT) inhibited replication of an immunodeficiency-inducing strain of feline leukemia virus (FeLV-FAIDS) in vitro at concentrations of 0.5-0.005 micrograms/ml. A 25-30% additional antiviral effect was achieved in vitro when AZT was combined with human recombinant alpha interferon 2a (IFN alpha). "
01/01/1990 - "Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS)."
04/01/1989 - "2',3'-dideoxycytidine (ddC) inhibits replication of the immunodeficiency inducing strain of feline leukemia virus (FeLV-FAIDS) in vitro at concentrations ranging from 1-10 micrograms/ml. Additive antiviral effect is achieved when ddC is combined with either human recombinant alpha interferon (IFN alpha) or tumor necrosis factor (TNF) plus IFN alpha. "
9. Glycoproteins (Glycoprotein)IBA
10. Antiviral Agents (Antivirals)IBA

Therapies and Procedures

1. Therapeutics
2. Joint Capsule Release
3. Intravenous Injections
4. Secondary Prevention
5. Immunotherapy